Withania somnifera (Ashwagandha) and very rare risk of liver injury
Medicine Safety Update
Published
Related content
-
More prominent safety warnings about the neuropsychiatric effects of montelukast
Additional safety information is being added to all montelukast products to strengthen and highlight existing warnings about serious neuropsychiatric events. -
Shingrix vaccine and very rare risk of Guillain-Barré Syndrome
We have received Australian reports of Guillain-Barré Syndrome (GBS) following Shingrix vaccination. -
Azithromycin and rare risk of cardiovascular death
An updated warning about the risk of sudden cardiovascular death has been added to the Product Information and Consumer Medicine Information documents for azithromycin.